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Abstract.  The molecules that mediate cell-matrix  rec- 
ognition,  such as fibronectins (FN) and integrins, 
modulate cell behavior.  We have previously demon- 
strated that FN and the Bl-integrins are used during 
neural crest cell (NCC) migration  in vitro as well as 
in vivo, and that the FN cell-binding domains I and II 
exhibit functional specificity in controlling either NCC 
attachment,  spreading,  or motility in vitro. In the 
present study, we have analyzed the effect of changes 
in the integrin expression patterns on migratory cell 
behavior in vivo. We have generated,  after stable 
transfection,  S180 cells expressing different levels of 
ot4B1 or ot5/51 integrins,  two integrins  that recognize 
distinct FN cell-binding domains.  Murine S180 cells 
were chosen because they behave similarly to NCC af- 
ter they are grafted into the NCC embryonic pathways 
in the chicken embryo. Thus,  they provide a model 
system with which to investigate the mechanisms con- 
trolling  in vitro and in vivo migratory cell behavior. 
We have observed that either the overexpression of 
tx5/$1 integrin or the induction of ot4/31 expression in 
transfected S180 cells enhances their motility on FN in 
vitro.  These genetically modified S180 cells also ex- 
hibit different migratory properties when grafted into 
the early trunk NCC migratory pathways. We observe 
that or5 and low oM expressors migrate in both the 
ventral and dorsolateral paths simultaneously,  in con- 
trast to the parental  S180 cells or the host NCC, 
which are delayed by 24 h in their invasion of the dor- 
solateral path.  Moreover, the c~4 expressors exhibit 
different migratory properties according to their level 
of ot4 expression at the cell surface.  Cells of the low 
or4 expressor line invade both the ventral and dor- 
solateral pathways. In contrast,  the high expressors re- 
main as an aggregate at the graft site, possibly the re- 
sult of ot4Bl-dependent homotypic aggregation.  Thus, 
changes in the repertoire of FN-specific integrins  en- 
able the S180 cells to exploit different pathways in the 
embryo and regulate the speed with which they dis- 
perse in vivo and in culture.  Our studies correlate well 
with known changes in integrin expression during neu- 
ral crest morphogenesis and strongly suggest that neu- 
ral crest cells that migrate into the dorsolateral path, 
i.e.,  melanoblasts, do so only after they have upregu- 
lated the expression of FN receptors.  Some of our in 
vivo results are at variance with what was expected, 
based on the in vitro behavior of the S180-transfected 
clones, and they demonstrate the importance of ex- 
amining  cell behavior in the tissue environment. 
I 
NTERACTIONS between cells and their environment  play 
a  crucial  role  in  the control  of cell  behavior during 
embryogenesis and  tissue  remodeling,  as  well  as  in 
numerous  pathological  states  (Hynes and  Lander,  1992; 
Edelman et al., 1990; Horwitz and Thiery, 1994; Adams and 
Watt,  1993). Cell-cell and cell-matrix adhesion  molecules 
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are important mediators of these interactions  and are de- 
velopmentally regulated.  The ontogeny of the neural crest is 
one particularly  striking  example of exquisite regulation  of 
cell  adhesion  during  morphogenesis.  Neural  crest  cells 
(NCC) t are initially  integrated  in the neuroepithelium  be- 
fore undergoing an epithelial-mesenchymal  conversion,  fol- 
lowed by extensive migration  throughout  the embryo to give 
rise to a plethora of cell types and structures (reviewed by 
1. Abbreviations  used in this paper: FN, fibronectin; HPSG, heparan-sulfate 
proteoglycan; NCC, neural crest cell. 
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ment from the neuroepithelium, subsequent migration, and 
cessation of  migration are regulated to a considerable degree 
by changes in cell-cell and cell-matrix attachments (reviewed 
by Erickson and Perris, 1993). Numerous experiments have 
emphasized the role of fibronectin (FN), in particular, in the 
adhesion and migration of NCC in vitro and in vivo (e.g., 
Boucaut et al., 1984; Bronner-Fraser, 1985; Duband et al., 
1986;  Dufour et al.,  1988). 
FN is a dimeric glycoprotein comprised of two major cell- 
binding domains that are recognized by different receptors 
belonging to the integrin family (reviewed by Hemler, 1991; 
Hynes, 1990,  1992;  Yamada,  1989).  The cell-binding do- 
main I,  or the central  cell-binding domain, contains the 
RGDS recognition motif  and an additional site, which act in 
synergy to regulate cell adhesion, migration, and matrix as- 
sembly (Akiyama et al.,  1990; Obara et al., 1988;  Aota et 
al., 1991; Nagai et al., 1991). This central cell-binding do- 
main is recognized by many of the integrins including .5/31, 
.3/31, .v/31, .v/33, .v/35, and .IIb~3. 
The second cell-binding domain in FN, called cell-binding 
domain II, is comprised of sequences located in the IIICS re- 
gion, and in the adjacent heparin-binding domain II (see Fig. 
4).  The amino acid sequences that mediate adhesion are 
LDV and REDV, located in the CSI and CS5 regions of the 
IIICS domain, respectively, and one IDAPS sequence lo- 
cated in the heparin-binding domain II. These sequences are 
recognized by the .4/~1 integrin (Garcia-Pardo et al., 1990; 
Guan  and  Hynes,  1990;  Mould  and  Humphries,  1991; 
Mould et al., 1991; Komoriya et al., 1991). Sequences that 
interact with cell surface heparan sulfate proteoglycans, and 
that promote focal adhesion formation, are also found in the 
heparin II domain (Woods et al., 1993; Woods and Couch- 
man,  1994). 
The cell-binding domains of FN have distinct functional 
activities, and are used by different  cell types in various com- 
binations. We have demonstrated that NCC in vitro interact 
with the cell-binding domains I and 1I of FN through El- 
containing integrins (Duband et al.,  1986;  Dufour et al., 
1988). The CSI sequence in cell-binding domain II is mainly 
used for attachment and motility, whereas the central bind- 
ing site (cell-binding domain I) is used for spreading, as well 
as for attachment and motility. Thus, based on what is cur- 
rently known about integrin specificity, NCC must use at 
least one of the RGDS-sensitive integrins (.5/~1, .v/31, and 
.3/31), as well as .4/31, when they attach and migrate in tis- 
sue culture. Moreover, both of the cell-binding domains are 
required to obtain the maximum adhesive and migratory 
capabilities on FN. In contrast, fibroblasts interact preferen- 
tiaily with the cellular binding domain I, whereas melanoma 
cells, which are malignant derivatives of the NCC, use pri- 
marily the cellular binding domain II (Humphries et al., 
1986,  1987). 
Although we know a  great deal about integrin function 
from in vitro studies, little is known about bow the integrins 
are involved in migratory events in the embryo. Indeed, our 
understanding of in vivo events is complicated by the fact that 
tissue-derived cells frequently alter the complement of pro- 
teins produced, including integrins, even after only a short 
exposure to culture conditions. For example, normal human 
melanocytes express a different repertoire of integrins in situ 
than when isolated and cultured (Zambruno et ai.,  1993). 
Thus, the relevance of the many tissue culture studies to the 
behavior of the same cells during embryogenesis is unclear. 
One way to address this issue would be to alter the expres- 
sion of specific integrins one at a time and to test the effect 
of these alterations on cell behavior in the embryo. It has not 
yet been possible to alter stably the repertoire of integrins 
on early migratory neural crest cells. However, the mouse 
sarcoma S180 cell line has been shown to behave similarly 
to neural crest cells when grafted into the NCC migratory 
pathways at the thoracic level (Erickson et al., 1980). There- 
fore, we have chosen S180 cells as a model system in which 
to modify the integrin expression pattern and subsequently 
test cell behavior in the embryonic environment. 
In this report, we have focused on the .4/~1 and .5/~1 inte- 
grins, since these interact specifically with the two distinct 
adhesion domains of FN known to be crucial for NCC motil- 
ity in vitro. We have generated stable transfectants of  the par- 
ent S180 cell line that express the human .4 or .5 chain. Ex- 
pression of either the .4 or the .5 chain at the surface of 
S180 cells promotes an increase in cell attachment, spread- 
ing,  and  motility on  FN  fragments  containing the  cell- 
binding domain 11 or on intact FN, respectively. These ge- 
netically modified S180  cells  exhibit different migratory 
properties when grafted into the early crest migratory path- 
ways. We demonstrate that the parent S180 cells migrate into 
the anterior half of the somite (the ventral pathway), but they 
do not invade the  space between the ectoderm and der- 
mamyotome (the dorsolateral path) during the first 24 h in 
the embryo, thus mimicking the behavior of the endogenous 
neural crest cells. The .5 expressors migrate in both the ven- 
tral and dorsolateral paths simultaneously, in contrast to the 
host neural crest cells, which are delayed in their invasion 
of the dorsolateral path until another 24-26 h (Serbedzija 
et al.,  1990;  Erickson et al.,  1992;  Oaldey et al.,  1994). 
Moreover, the transfected cells exhibit long processes,  in 
contrast to the rounded morphology and short processes of 
the parent cell line. Finally, the .4 expressors exhibit differ- 
ent migratory properties according to their level of .4 ex- 
pression at the cell surface. Cells of the low expressor line 
invade both the ventral and dorsolaterai pathways,  but they 
are generally spread on the basement membranes and are in- 
frequently found in the interstitial matrix. In contrast, the 
high expressor cells remain as an aggregate at the site of 
grafting, even though they exhibit obvious cell processes. 
Thus,  the complement of integrins expressed enables the 
S180 cells to exploit different  pathways in the embryo, as well 
as to regulate the speed with which they disperse. Some of 
these results are contrary to what was expected, based on the 
behavior of the same cells in culture, and they demonstrate 
the importance of examining cell behavior in the tissue envi- 
ronment. 
Materials and Methods 
Antibodies and Reagents 
Rat monoclonal antibodies mAbl6 and mAbl3 directed against human cc5 
and/31 integrin chains, respectively, were a generous gift of Dr. K. Yamada 
(National  Institutes of Health,  Bethesda,  MD;  Akiyama et  al.,  1989). 
Monoclonal antibody L25 directed against the human or4 integrin chain was 
purchased from Becton Dickinson Immunocytometry Systems (Mountain 
View, CA). Rabbit polyclonal antibodies directed against the carboxytermi- 
nus of the cd, c~2, ct3, ix5, and c~v human chains were a generous gift of 
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cangeli et al., 1993).  Control rat IgG and mouse IgG were purchased from 
Sigma Immunochemicals (St. Louis, MO). Peptides HI20, H89, H95, and 
H0 (see Fig. 4) corresponding to different spliced forms of the IIICS region 
of human fibronectin (herein referred to as llICS-spliced fragments) were 
made as described in Mould et al. (1994).  The pFNR~5 eukaryotic expres- 
sion vector coding for the human et5 chain of integrin was a generous girl 
of Drs. E  G. Giancotti and E. Ruoslahti (Cancer Research Institute, La 
Jolla, CA: Giancotti and Ruoslahti,  1990). 
Construction of the Human ~4 Expression Vector 
The pKSc~4 cloning vector coding for the full-length a4 eDNA was a gener- 
ous gift from Dr. M. Hemler (Dana Farber Cancer Institute, Boston, MA; 
Takada et al., 1989).  A KpnI-AflRI insert (KA insert) was amplified from 
pKSct4  by  PCR  using  the  (5'-IV_AGCACATGTTCATTAATCATCATTO- 
CTTTT-3 ~) and the (5'-TAATGGTACCAAATTCTTTT-3') oligonucleotides 
(antisense and sense, respectively) and digested with Kprd and AflIII re- 
striction enzymes. This was done to create an AflIII restriction site after 
the stop codon of the t~4 eDNA sequence. The SalI-KpnI insert (SK insert) 
of the pKSt~4 was purified from an agarose gel. The pFNt~5 expression vec- 
tor was digested with Sail and NCOI restriction enzymes to eliminate the 
a5 eDNA translated sequence. Both the SK insert and PCR-primed KA in- 
sert from pKSt~4 were inserted into the SalI-NcoI sites of the pFNRot5 vec- 
tor to obtain the expression vector pFNc~4 coding for the human c~4 integrin 
subunit. In this construct, the coding sequence for the human c~4 chain was 
linked to the 3' noncoding sequence of the ct5 subunit to abolish possible 
regulatory effects  of  different 3' noncodiog sequences on the mRNA stability 
or  subunit  expression.  The  integrity  of  the  pFNRa4  construct  was 
confirmed by sequence analysis. 
Cell Culture and Transfection 
The sarcoma S180 cells used in this study are a subclone derived by Dr. 
K. Yamada (National Institutes of Health, Bethesda, MD) from the original 
parental cell line, which was obtained from American Type Culture Collec- 
tion (Rockviile, MD). These cells were selected for their inability to assem- 
ble an FN matrix at their cell surface. The cells were cultured in DME 
supplemented  with 10% (vol/vol) FCS (Polylabo, Strasbourg, France). Sar- 
coma cells were stably transfected with either the pFNRc~5 or pFNRct4 
expression vector by the phosphate calcium method according to Gorman 
(1985).  The cells were cotransfected with pAG60, which codes for the neo- 
mycin selection marker. Neomycin-resistant cells were analyzed for the ex- 
pression of human c~5 or human c~4 by FACScan  ® analysis (Becton Dickin- 
son) using the mAbl6 and L25 monoclonal antibodies, respectively. The 
L27 expressor clone for human c~5 chain and the P22 control neomycin- 
resistant clone were chosen for further in vitro and in vivo analysis. Stable 
expressor clones for the human c~4 chain that were selected initially showed 
heterogenous levels of expression of this chain at their cell surface. They 
were subsequently subcloned to  obtain a  homogenous population.  The 
D711 (high) and D828 (low) expressor clones and the B8 control neomycin- 
resistant clone were subsequently chosen for further in vitro and in vivo 
analysis, The stability of the expression level of human integrin ¢~ chain in 
the transfectants was verified by flow cytometry every several passages. 
Cell Surface Labeling and Immunoprecipitation 
Ceils were surface-labeled with 125I (Amersham Corp., Arlington Heights, 
IL)  as previously described (Rossino et al.,  1990).  Briefly,  cells were 
released from culture dishes by 5 mM EDTA treatment in PBS and washed 
three times after centrifugation with culture medium. Cells were resus- 
pended in PBS containing CaCI2 (1 raM) and MgC12 (1 raM) and labeled 
with 1 mCi of t2sI in the presence of lactoperoxidase (200/~g/mi; Sigma) 
and H202  (0.002%).  To determine which integrins are expressed in S180 
and transfected clones, labeled cells were treated as previously described 
(Defilippi et al., 1991a).  Briefly,  labeled cells were washed with cold PBS 
and extracted for 20 rain at 4"C with 0.5% Triton X-100 in 20 mM Tris- 
HCI, pH 7.4,  150 mM NaC1 (TBS) with 1 mM CaC12, 1 mM MgCI2,  10 
t~g/ml leupeptin, 4 t~g/ml pepstatin, and 0.1 TIU/mi of aprotinin (all from 
Sigma). After centrifugation at 10,000 g for 10 rain, extracts were incubated 
with specific antibodies conjugated to protein A-Sepharose beads (Pharma- 
cia Fine Chemicals, Piscataway,  NJ) for 1 h at 4°C with gentle agitation. 
After washing, bound material was eluted by boiling the beads in 1% SDS, 
separated using 6% SDS-PAGE, and autoradiographed. The autoradiogram 
was digitized using a video camera (612F Data Copy) linked to an acquisi- 
tion module and a graphic control unit, which were designed by the staff 
of the Computer Science Laboratory of the Ecole Normale Sul~rieure. A 
band profile was obtained for each c~ subunit, and these were subsequently 
analyzed using the HERMES software (Vincent et al., 1986) to quantify the 
intensity of each band (arbitrary units). 
Assays for Cellular Adhesion and Spreading 
Cell adhesion of the L27, P22, B8, D711,  and D828 clones to FN-coated 
substrata and to IIICS-contalniog fragments (HI20, H89, H95, and H0; see 
Fig. 4) were tested as described in Dufour et al. (1988). Cellular attachment 
and spreading assays were performed on bacteriological petri dishes. 20-~1 
droplets of hpFN (10/~g/mi) or [IICS-spliced fragments (2-20 ~g/ml in 
PBS) were deposited on bacteriological dishes and incubated at 37°C for 
1 h, followed by a 30-rain incubation with 3 mg/mi solution of BSA in PBS 
(previously heat inactivated for 3 rain at 80°C). After extensive washing, 
the substrata were maintained in PBS until used. Cells were harvested with 
a  solution of 0.25%  trypsin and  1 mM  EDTA  in  PBS  (GIBCO  BRL, 
Gaithersburg, MD) for 5 rain at 37°C. After centrifugation at 1,200  rpm', 
cells were incubated for 1 h in DME supplemented with 10% (vol/vol) FN- 
depleted fetal calf serum to allow recovery from trypsin treatment. 2,000 
cells were deposited on the precoated substrata. The dishes were incubated 
at 37°C for various times, rinsed with PBS to remove the nonadherent cells, 
and fixed in 3.7% formaldehyde in PBS. Attached and spread cells (any cell 
that had extended cell processes  and had begun to flatten) were counted with 
an inverted phase contrast microscope (E. Lcitz, Inc., Rockleigh, N J). At 
least three independent experiments were done for each substratum and for 
each of the clones tested. 
Specificity of adhesion was tested by challenging the cells with antifunc- 
tional antibodies against the ~5 or or4 subunit. Transfected cells were plated 
on either FN or the IIICS-spliced fragments for 30 min. The medium was 
subsequently rinsed, and adherent cells were incubated in the presence of 
monoclonal antibodies mAbl6 or L25 at various concentrations for 30 min. 
The cultures were then rinsed with PBS to remove nonadherent cells, fixed 
with 3.7%  formaldehyde in PBS, and counted as described above. FOr all 
compared values, the statistical significance was determined using a  X~  2 
test, with a level of confidence >95 %. 
Assay for Cell Migration 
Speed of movement was assessed using two different assays. In the first, the 
rate of individual cell movement was analyzed using time-lapse video- 
microscopy. Glass coverslips were coated with hpFN (30 ttg/mi) or with 
IIICS fragments (6/zg/mi), followed  by an incubation with 3 mg/ml of BSA. 
S180-transfected cells were deposited on these substrata in DME containing 
10%  FN-depleted fetal calf serum. For time-lapse videomicroscopy, cul- 
tures were maintained at 370C  in a plexiglass chamber on the stage of a 
Leitz Laborlux phase-contrast microscope and their behavior was recorded 
using a time-lapse videorecorder (Panasonic; Matsushita Electric Industrial 
Co., Ltd., Japan). Paths of migration of 20 cells were traced from the video 
monitor onto transparent paper. This was done for two independent experi- 
ments. The total distance of migration was measured and the speed of loco- 
motion was calculated. The results of cells migrating on intact FN are ex- 
pressed as an increase in speed of movement of the transfected cells when 
compared to that of the control. This increase is calculated as the ratio be- 
tween the mean speed of locomotion calculated for the c~-expressor clones 
(tv) and the mean speed calculated for the control clones (cv). 
In the second test, cell migration was quantitated by determining the ex- 
tent of migration from agarose droplets using a modification of the method 
described by Varani et al. (1978). Briefly, cells were harvested as described 
previously and resuspended at 33  ×  106 cells/ml in bicarbonate-free DME 
containing 25 mM Hepes, pH 7.4 (GIBCO BRL), and 0.2% agarose (Sea 
Plaque; FMC Corp. BioProducts, Rockland, ME) maintained at 39"C. The 
cells were plated as 0.8-#1 droplets on flat-bottom wells (microtest HI flexi- 
ble 96-well assay plates, nontissue culture treated; Falcon Plastics, Cock- 
eysville, MD) that were precoated with 10/~g/ml hpFN. After the agarose 
was gelled, 100 pl of culture medium was added with care to avoid detach- 
ment of droplets. To specifically inhibit attachment mediated by c~5~1, ei- 
ther the monoclonal antibody mAbl6 or control rat IgG was added to the 
culture medium at a final concentration of 0.1 mg/ml. Ceils were cultured 
at 37°C for various times and then fixed with 3.7%  formaldehyde. After 
rinsing, the cells were stained with 1% crystal violet in ethanol, destained 
in water, and air dried. The cultures were photographed, and total area of 
cell outgrowth was measured. The results are expressed in arbitrary units. 
For all  the compared values, the statistical significance was determined 
using a X~  2 test, with a level of confidence >95%. In all the figures, the er- 
ror bars represent SD. 
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The ceils to be grafted were cultured in 30-ml tissue culture flasks (Coming 
Inc., Coming, NY) in DME until 50% confluent.  Just before grafting,  the 
medium was removed and replaced with 4 ml of culture medium containing 
24 t~l of Fluoro-goid  stock solution (2%  in Locke's saline; Fluorochrome 
Inc., Englewood,  CO).  The cells were incubated with the Fluoro-gold  for 
4 h, at which time the labeling medium was removed and the cells washed 
three times in Hanks' balanced salt solution (GIBCO BRL) to remove all 
residual label. The ceils were rinsed with 2.5% Pancreatin in PBS (GIBCO 
BRL) and the flasks gently rapped against the palm of the hand to detach 
the cells from the substratum. Culture medium was added to the flasks to 
stop the tryptie action and to suspend  the cells.  The cell suspension was 
gently centrifuged,  the cell pellet resuspended in fresh culture medium, and 
incubated for 2 h in a 37°C water bath for the cells to reconstitute membrane 
proteins.  The cells were then repelleted  by centrifugation,  the pellet trans- 
ferred to a petri dish containing sterile Locke's saline,  and lightly stained 
with a few drops of 0.2%  neutral red. 
Grafting Experiments 
White Leghorn chicken embryos were incubated at 38°C until they had tie- 
veloped 20-23 somite pairs,  corresponding to stages  13-14 (according  to 
the criteria of Hamburger and Hamilton, 1951). The eggs were cracked into 
a finger bowl of sterile Locke's saline and the blastoderms were cut out and 
transferred with a wide-mouth  pipette to an agar-coated  dish. The embryo 
was oriented dorsal  side-up and spread so that it lay fiat and the somites 
could be readily counted.  A small portion of the cell pellet (50-100 cells) 
was pipetted onto the embryo with a Spemann pipette and gently maneu- 
vered with a tungsten needle through a slit in the ectoderm made between 
the neural tube and somite at the axial level five somites from the last formed 
somite.  This is the axial  level where neural crest cells have just migrated 
off the dorsal  surface of the neural tube (cf. Loring and Erickson,  1987). 
To aid in the relocation of the graft site after sectioning,  a small amount 
of blood charcoal  was inserted into the center of the somite two segments 
posterior to the graft site. The embryo was then carefully  picked  up with 
a ring of filter paper and suspended  on a nucleopore filter (polycarbonate, 
8 #m pores) over the well of an organ culture dish (Falcon) that was filled 
with L15 medium (GIBCO BRL) supplemented with 10% FCS.  The em- 
bryos were returned to the 38°C incubator for an additional  18 h and then 
fixed. 
Histology 
Embryos were fixed in 4% paraformaldehyde  for 2 h, washed with PBS, 
and a region of the embryo six somites in length encompassing  the graft 
cut out with tungsten needles.  Embryo pieces were washed for 3 h in 3 % 
BSA in PBS and then incubated overnight at 4°C in the HNK-1 antibody 
(hybridoma ascites;  1:250 in PBS/BSA) to label the neural crest cells. The 
unbound antibody was washed out during a 3-h incubation in 0.5 % BSA in 
PBS, and the specimens were immersed overnight in the secondary antibody 
(rhodamine-conjugated  goat anti-mouse whole antibody, 1:50 in PBS; Cap- 
pell Laboratories, Cochranville, PA). After several rinses in PBS the speci- 
mens were postfixed in 0.1% paraformaldehyde  for 1 h, dehydrated  in ace- 
tone, and embedded in Spurr's plastic.  The specimens  were sectioned  at 3 
#m on a Histodiamond knife from Diatome U.S. (Fort Washington,  PA) 
using  an ultramicrotome (MT-2;  Sorvall  Instruments, Wilmington, DE), 
and the serial sections were collected on glass slides in individual drops of 
water.  After the sections dried to the slide,  they  were  mounted in 70% 
glycerol containing 0.1 M NaHCO3, pH 7.8, and 2% n-propyl gallate as an 
antioxidant,  and were viewed with a Leitz Dialux 20 microscope  equipped 
with epifluorescence  and a Vario Orthomat camera. 
Results 
Cell Transfections and Integrin Pattern Expression at 
the Cell Surface 
At least in vitro, NCC use different members of the integrin 
family,  apparently including a4/31  and ~5/31,  to adhere to 
and migrate on FN (Dufour et al., 1988). To study the poten- 
tial role of these two integrins in in vivo migration, we have 
modified their expression in S180 cells, since these cells are 
Figure 1.  Repertoire  of integrins expressed by the parental S180 
cells and transfected clones.  ~25I surface-labeled extracts of paren- 
tal S180 cells were immunoprecipitated with polyclonal antibodies 
directed against the cytoplasmic sequence of cd, c~2, c~3, a4,  u5, 
and  c~v  integrin  chains.  125I surface-labeled  extracts  of  high 
(D711) and low (D828) cx4-expressor cells were immunoprecipi- 
tated with a  polyclonal antibody directed against the c~4 integrin 
chain.  Similarly,  ~25I surface-labeled  cells  of the  a5  expressor 
clone L27  were  immunoprecipitated  with a  polyclonal  antibody 
directed against the a5 integrin chain. Note that the S180 cells do 
not express detectable levels of et 1, c~2, and or4 chains. These cells 
express high levels of a3 and c~v and low levels of the c~5 integrin 
chain. The/31 chain coprecipitates with the c~3 and a5 chains; c~v 
coprecipitates with both the/31 and/33 chains. The/35 subunit was 
not  detected  in  the  av  immunoprecipitate.  There  is  a  fourfold 
difference in expression of the ¢x4 integrin chain between the D711 
and  D828  cells,  as  measured  by  scanning autoradiography.  The 
lower band detected at 80 kD corresponds to a proteolytic cleavage 
product of the c~4 chain,  as previously observed (Teixido et al., 
1992).  The L27 cells express high levels of the ~5/31  integrin at 
their surface. A fivefold increase in the level of the c~5 chain in L27 
ceils  was  measured  by  scanning  the  autoradiograph.  Elec- 
trophoretic mobility of high molecular mass markers (kD) is indi- 
cated on the vertical axes. 
known to mimic some of the migratory behavior of early 
migrating trunk NCC (Erickson et al.,  1980). Before trans- 
fection, it was essential to determine the prevalence of the 
various integrins expressed at the surface of S180 cells. We 
performed surface labeling and immunoprecipitation of cell 
extracts with different polyclonal antibodies specific for od, 
c~2, c~3, c~4, ~x5, and av subunits (Arcangeli et al., 1993; De 
Filippi et al.,  1991a,b).  As shown in Fig.  1, control S180 
cells do not express detectable levels ofod, or2, or c~4 chains. 
They express high levels of the or3 chain and low levels of 
oz5. The/31  chain coprecipitates with both the or3 and or5 
subunits.  S180  cells express  high levels  of the oce chain, 
which coprecipitates with the/31  or 133 subunits.  We could 
not detect the/35 chain (which can also associate with av) 
in the immunoprecipitates. 
Since the S180 cells produce low levels of a5/31 and virtu- 
ally no ~4/31, we cotransfected S180 cells with pFNo~4 or 
pFNa5  expression vectors, which code for the human or4 
and or5 integrin chains,  respectively, and with the pAG60 
vector  coding  for  neomycin resistance.  After  selection, 
resistant clones were immunolabeled with the L25 or mAbl6 
monoclonal antibodies, which are directed against the hu- 
man or4 and cx5 chain, respectively, and were subsequently 
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Figure 2. Flow cytometry was used to quantitate the expression of 
human ct4 and a5 integrin chains at the surface of mouse S180 
transfected cells.  The abscissa represents  the  logarithm of the 
fluorescence intensity, and the ordinate represents the number of 
cells at each level of intensity. (A) Histogram obtained after im- 
munolabeling of two pFNRtx4-transfected clones with L25 mono- 
clonal  antibody  specific for the  human  c~4 chain.  The control 
neomycin-resistant clone B8 (unfilled  peak) does not express the 
human c~4 integrin chain. The two expressor clones D828 and D711 
(filled  peaks ) express moderate and high levels of  human or4 chain, 
respectively, at their cell surface. (B) Histogram obtained after im- 
munolabeling of a pFNRc~5-transfected  clone with mAbl6 mono- 
clonal antibody directed against the human ct5 chain. The P22 con- 
trol neomycin-resistant clone (unfilled  peak ) does not express the 
human tx5 integrin chain. The L27 cells (filled  peak ) express high 
levels of the human c~5 integrin chain. 
analyzed by flow cytometry (Fig.  2).  Initially, the clones 
selected for tx4 expression exhibited heterogeneous levels of 
this subunit at the cell surface. Subcloning allowed us to se- 
lect for low and high human o~4 expressors, named D828 and 
D711  (Fig. 2 A).  The D828 cells contain low amounts of 
ot4131, whereas the D711 cells express four times as much 
c~4/31 as the D828 cells (Fig. 1). These clones were used for 
further analysis, as well as the B8 control neomycin-resistant 
clone.  The highest  expressor clone obtained  after stable 
transfection with pFNa5, called L27, expressed five times 
the level of a5/31 integrin as the parent S180 line (Figs. 1 and 
2 B). L27 and a control neomycin-resistant clone, P22, were 
selected for further analysis. All the or4 and or5 expressor 
cells, as well as the control cells, expressed the same level 
of ot 3 and ctv integrin chain at their cell surface, as revealed 
by a flow cytometry analysis (data not shown). 
In Vitro Attachment and Spreading of ~5 and ~4 
Expressor S180 Clones 
Functional activity resulting from an increased expression of 
tx4 or ct5 integrin chain at the surface of transfected S180 
cells was first tested in attachment and spreading assays on 
specific substrata. The L27 (c~5 expressor) cells and the con- 
trol P22 cells were tested on an FN-coated substratum. As 
shown in Fig. 3 A, 56.3% of the P22 cells are able to adhere 
and 29.5 % to spread on an FN-coated substratum in <20 rain. 
Cells of the L27 clone, which express five times the amount 
of the o~5/31 integrin at their cell surface, are able to interact 
more efficiently with the FN-coated substratum;  85.7%  of 
L27 cells are attached and 67.5 % are spread after 20 rain. 
The percentage of  ceUs that are attached increases with time, 
and by 120 min, there is no significant difference in the per- 
centage of attached cells between the two cell lines (92 % of 
P22 attached vs 98 % of L27 cells attached). 
In contrast, the percentage of cells that are spread is con- 
sistently  different between  the  two  cell  lines  at  all  time 
points; by 120 min, 82.6% of the P22 cells are spread, in 
contrast with 96% of  the L27 ceils. Not only do the L27 cells 
spread faster, but they also display a flatter morphology and 
greater degree of spreading (Fig. 3 Bb) compared to the P22 
cells (Fig. 3 Ba). This increase in spreading can be abolished 
in the presence of the monoclonal antibody mAbl6, which 
is specifically directed against the human integrin or5 chain 
(0.1 mg/ml; Fig. 3 Bc), whereas control IgG at the same con- 
centration (Fig. 3 Bat) has no effect on L27 cell morphology. 
Thus, the change in morphology is caused by the elevated ex- 
pression of or5 chain. 
The S180  cells cannot assemble FN matrix at their cell 
surface, except at high density. We have observed that the 
L27 cells can initiate FN fibril formation at their cell surface, 
even at subconfluency, whereas control S180 cells or ct4 ex- 
pressor cells do not assemble FN fibrils under these condi- 
tions. L27 cells also incorporate FN into their pericellular 
matrix at confluency to a  greater extent than control cells 
(data not shown). 
The functional activity resulting from the cell surface ex- 
pression of a4/31 integrin on cells from the D828 and D711 
clones was tested in in vitro attachment and spreading assays 
on different spliced variants of the adhesive domain II (Fig. 
4), as well as on intact FN. All of these variants contained 
the amino acid sequences corresponding to the 14th,  15th, 
16th, and 17th type HI homology domains of  human FN. The 
16th and 17th type IIl homology sequences were interrupted 
either by the entire IIICS domain (H120), the CS5-spliced 
IIICS domain (H89), the CSl-spliced IIICS domain (H95), 
or directly joined to each other (H0; without the IIICS do- 
main). The H120 spliced variant corresponds to the entire 
cell-binding domain II of FN,  whereas the REDV- or the 
LDV-cell-binding site is removed, in H89 and H95, respec- 
tively. The LDV and REDV sites are both missing in H0. All 
of these spliced variants still contain the IDAPS sequence 
recognized  by  a4/31  integrin  and  also  heparan-sulfate- 
proteoglycan-binding sites located in the heparin-binding II 
domain. 
The attachment and spreading assays were performed for 
30 min on substrata made using 2- or 10-t~g/ml coating solu- 
tions of each IIICS-spliced variant. The B8 control cells ad- 
here poorly to H120-, H89-, H95-, and H0-coated substrata 
(<5 %) and cannot spread on them (Fig. 5 A). This is consis- 
tent with the fact that we could not detect the ot4/31 integrin 
at the surface of $180 cells (Fig.  1). Expression of a4~1 on 
D828 and D711 cells (low and high expressors, respectively) 
promotes cell attachment on H120-, H89-, and H95- coated 
substrata,  which  contain the LDV  and/or the  REDV  se- 
quence.  The percentage of adherent cells depends on the 
concentration of the solution used to coat the substratum 
(Fig. 5 A). It is noteworthy that D711 cells attach much more 
efficiently (58%) than the D828 cells (17%) on the H120- 
coated substratum (2 #g/ml). Similar values were observed 
on the H89-coated substratum. In contrast, these cells can- 
not adhere to the H95- and H0-coated substrata (2 #g/ml). 
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Figure 3. Adhesion and morphology 
of L27 and P22 cells on fibronectin- 
coated substrata. (A) Adhesion assay 
performed with L27 (black) and P22 
(white)  cells  on  fibronectin-coated 
substrata. At 20, 45,  or 120 rain of 
the assay, nonadherent cells were re- 
moved, and adherent cells fixed and 
counted to determine the percentage 
of attached (square)  or spread (cir- 
cle) cells. Note that the L27 cells are 
able  to  attach  and  spread  more 
efficiently than the control cells on a 
fibronectin-coated substratum.  The 
difference is more clearly seen dur- 
ing short periods of incubation (20 
and 45 rain); at 120 rain, there is not 
a significant  difference seen between 
the control and L27 cell lines. For 
all compared  values,  the  statistical 
significance was determined using a 
Xl  e test,  with a  level of confidence 
superior to 95 %. (B) Morphology of 
L27 ceils (b-d) and P22 ceils (a) at 
24  h.  On a  fibronectin-coated sub- 
stratum, L27 cells have a more flat- 
tened and highly spread morphology 
(b, arrowheads)  when compared to 
the control cells (a). The increase in 
spread morphology of the L27 cells 
can  be  reversed  when  0.1  mg/ml 
of m.Abl6 antibody (specifically di- 
rected against the human ,5 chain) is 
added  to  the  culture  medium  (c), 
whereas  control  Igs  have  no  ef- 
fect (d). 
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Figure 4. Variants of the human FN cell-binding domain II contain- 
ing different spliced forms of the IIICS region.  All the fragments 
contain  the  14th, 15th, and  16th FN type III homology regions 
(white rectangles), which  together  correspond  to  the  heparin- 
binding domain II and the 17th FN type III homology region. The 
heparin-binding domain II possesses one adhesion site recognized 
by the c¢4/31 integrin (black rectangle). It also contains adhesion 
sites that interact with beparan-sulfate proteoglycans (hatched rec- 
tangles). The H120 fragment corresponds to the entire cell-binding 
domain II of FN, with the IIICS region (120 amino acids) inserted 
between the  16th and  17th FN type III regions. The IIICS region 
contains two adhesion sites (black) specific for the c~4/~1 integrin: 
the LDV sequence in the CS1 domain and the REDV sequence in 
the CS5 domain. The H89 and the H95 fragments contain, respec- 
tively, the CS5-spliced form and the CSl-spliced form of the IIICS 
region in the cell-binding domain  II. The H0 fragment does not 
contain the IIICS region. 
Increasing the concentration of the H120 and H89 fragments 
used to coat the substratum (10 ttg/ml) resulted in an increase 
in the percentage of adherent cells to 85 and 78% for D828 
cells and to 82 and 60% for D711 cells, respectively. On the 
H95-coated substratum (10/zg/ml), 60% of the D828 cells 
and 67% of the D711 cells adhere. In contrast, only 1% of 
either of these two expressor cells was able to interact with 
the  H0-coated substratum.  The percentage of cell attach- 
ment can be increased when the assay is performed for a 
longer period of time (4-6 h) without any significant increase 
in cell spreading.  These results suggest that attachment of 
these expressor clones by way of the ol4/~1 integrin is largely 
mediated by the LDV sequence and, to a lesser extent, by 
the REDV sequence. 
At a higher coating concentration of the H0 fragment (20 
/~g/ml), an increase in cell attachment that was independent 
of the transfected cells used was observed (B8,  D828,  and 
D711;  data not shown). This is probably caused by interac- 
tion of cell surface proteoglycans with the heparin-binding 
II domain of the peptides. 
Cell spreading was also markedly different, depending on 
the level of ot4/~l expression at the cell surface. 2% of the 
D828 ceils vs 42%  of the D711  cells were spread on sub- 
strata coated with a  2/zg/ml solution of H120.  Similarly, 
38% of the D828 ceils vs 78% of the D711 cells were spread 
on  substrata coated with  10/zg/ml  of H120.  Comparable 
results were observed on the H89-coated substrata. No cell 
spreading was observed on substrata coated with 2 ~g/ml so- 
lution of H95. In contrast, 3% of D828 cells vs 29% of D711 
cells were spread on substrata coated with the 10 #g/ml H95 
solution.  No  spreading  was  observed on  H0-coated sub- 
strata. 
The attachment and spreading of D711 cells on H120- and 
H89-coated substrata could be specifically inhibited by the 
monoclonal antibody L25  directed  against the human  04 
chain, or by the CS1 peptide (Fig. 5 B). 70-80% inhibition 
of cell  attachment  and  spreading  was  observed using  10 
~g/mi of L25 on HI20- and H89-coated substrata, respec- 
tively, whereas control IgG had no effect. In contrast, the in- 
hibitory effect obtained with the CS1 peptide was more pro- 
nounced on cell spreading than on ceU attachment; D711 cell 
attachment and spreading were inhibited by 23 and 40%, 
respectively, on H120-coated substratum when treated with 
I mg/ml of CS1 peptide. These results indicate that cell adhe- 
sion and spreading observed on H120- and H89-coated sub- 
strata are mediated by the c~4~1 integrin, which is expressed 
in an active conformationai state at the surface of D828 and 
D711  cells. 
In Vitro Motility of  t~5 and t~4 Expressor S180 Clones 
L27, D828, D711, and control P22 and B8 cells were sparsely 
plated on FN-coated substrata or substrata coated with IIICS 
fragments, and the mean of the speed of locomotion was cal- 
culated for the expressor clones (tv) and the control clones 
(cv; Fig. 6 A). Overexpressor cell lines for the ot5~l or ot4/~l 
integrins increase their speed of movement on FN-coated 
substrata.  A  marked difference is observed for D711  cells 
(high or4 expressors), which exhibit a  3.2-fold increase in 
cell motility over controls, compared to a  1.3- and 1.4-fold 
increase obtained for L27 and D828 cells, respectively. The 
increase in D711  cell motility can be substantially inhibited 
when either the L25 antibody (specific to or4 subunit) or CS1 
peptide is added to the culture medium (Fig.  6 A). 
The B8, D828, and D711  cells were also tested for their 
ability to use the cell-binding domain II as a substratum for 
locomotion (Fig.  6  B).  B8  cells adhere poorly on all the 
IIICS fragment-coated substrata used, and they do not use 
these substrata for locomotion. In contrast, we observed that 
H120- and H89-coated substrata can promote cell motility 
of 04 expressor clones, depending on the level of expression 
of this integrin at the cell surface. The D711  cells (high or4 
expressors) migrate at a speed of  46/zm/h, whereas the D828 
cells (low 04 expressors) migrate at 19 I~m/h  on H120-coated 
substrata. A similar result was observed on H89-coated sub- 
strata; we recorded speeds of 39 and 12/zm/h for D711 and 
D828 cells, respectively. These cells can use the H95- or the 
H0-coated substrata for locomotion only to a limited extent, 
probably owing to the IDAPS found on the heparin-binding 
domain of these fragments. 
The Varani assay was also employed in our studies since 
it uses cells embedded at high density in agarose droplets, 
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D711 cells and control B8 cells on IIICS fragments 
(A) and inhibition of D711 cell adhesion on these 
coated substrata by CS1 peptide or L25 monoclo- 
nal antibody (B). (A) Adhesion assay for control 
B8  cells  and  t~4  low  and  high  expressor cells 
(D828 and D711) on substrata coated with solu- 
tions of IIICS fragments at 2  or  10 #g/ml.  The 
cells were incubated for 30 min at 37°C, then fixed 
and the adherent cells were counted.  Upper and 
lower panels indicate the means and standard devi- 
ations of the percentages of total cell attachment 
and spreading, respectively, for each clone. HI20 
(black square),  H89  (white square),  H95  (black 
circle),  and H0 (white circle).  Note that the B8 
control cells cannot adhere significantly to any of 
these  substrata.  On  CSl-containing  fragments 
(H120 and H89), the a4 expressor clones adhere 
proportionally  to the level of ~4/31 at their cell sur- 
face;  a  marked  difference in  attachment  is ob- 
served between the D828 and DTll cells on sub- 
strata coated  with  2  #g/ml  solution.  Similarly, 
there is a difference between the two cell lines in 
the ability to spread on substrata coated with ei- 
ther 2- and 10-1zg/ml  solutions; the high expressor 
c~4/31 cells have  a  greater ability to  attach and 
spread. On CSl-spliced fragments (1-195  and HO), 
no cells can adhere on  substrata coated with 2 
/~g/ml solution. At higher concentrations of these 
substrata, the c~4 expressor clones can adhere only 
on the CSS-containing fragment, but to a  lesser 
extent than on the CSl-containing fragments. (B) 
The CS1 peptide and the L25 monoclonal antibody 
can inhibit the attachment (black rectangle) and 
spreading (hatched rectangle)  of D711 cells on 
HI20- and  H89-coated substrata.  The  cells are 
plated on  the  substratum  for  30  min,  then  the 
medium  is  removed  and  adherent  cells are  in- 
cubated in the presence of antibodies for 30 min. 
The L25 antibody (even at the very low concentra- 
tion of 1/~g/ml) inhibits more efficiently than the 
CSI peptide. For all compared values, the statisti- 
cal significance was determined using a X] 2 test, 
with a level of confidence >95 %. 
which may mimic the escape of cells from an aggregate that 
has been implanted in the embryo (see results below). The 
area  of outgrowth  was  measured  at  two  time  points.  As 
shown in Fig. 7,  L27 cells exhibit a  30%  increase in their 
area of outgrowth  when  compared to that of control P22 
cells. This increase is statistically significant, and it can be 
specifically inhibited when  mAbl6 is added to the culture 
medium,  whereas control IgG has no effect.  An enhanced 
difference between L27 and P22 areas of outgrowth (100% 
increase) was observed when measured after a longer period 
of time (40 h). In contrast, no difference in the area of cell 
outgrowth is observed between the control B8 cells and the 
D828 and D711  a4 expressor cells in this assay either at 24 
or 40 h  (data not shown). 
In Vivo Behavior of Transfected Clones 
Both the parent $180 cell line and the transfected clones were 
grafted into the early neural crest migratory pathway to as- 
sess their behavior in an embryonic environment.  All cells 
were inserted into the embryo at the axial level where neural 
crest cells have just reached the dorsal margin of the somites 
(i.e., the fifth somite anterior to the last formed somite). Be- 
havior of the cells was assessed by fixing the host embryos 
18-24 h  after receiving the graft. 
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Figure 6.  Motility assay of transfectants on FN- 
coated  substrata  (A)  or  RICS  fragment-coated 
substrata (B). (A) The speed of locomotion of 20 
isolated cells in culture was measured using time- 
lapse videomicroscopy. The mean speed of loco- 
motion (cv) obtained for control cells P22 and B8 
was used as the reference to calculate the increase 
of speed of locomotion obtained with the expres- 
sor cells (tv). The ratio tv/cv corresponds to the 
value of increase of cell motility. Note that the 
D711 cells exhibit a marked increase in their speed 
of locomotion on a FN-coated substratum when 
compared to that obtained for D828 or L27 cells. 
The high cell motility of the D711  cells can be 
greatly  reduced  when  specific competitors are 
added to the medium; L25 monoclonal antibody 
at 100/~g/ml (black rectangle) or CS1 peptide at 
1 mglml (hatched rectangle). * The increase of the 
speed of  locomotion measured for the ot expressors 
vs the control cells and the inhibition obtained 
with  the  competitors is  statistically significant. 
(B) The speed of locomotion of 20 c~4 expressor 
cells and control cells was measured on IIICS frag- 
ment-coated substrata. The few B8 cells adhering 
to these substrata cannot migrate on them in con- 
trast to D82g and D711 cells, which can locomote 
actively on CSl-containing fragments. The ability 
of cells to migrate on H120- or H89-coated sub- 
strata depends on the level of or4 expression at the 
cell surface. On the H0- or H95-coated substrata, 
the D828 or D711 cells exhibit the same residual 
migratory activity, which is probably caused by 
the interaction of o~4/~1 integrin with the IDA site 
present in the heparin-binding II domain.  * The 
speed of locomotion obtained for the D828  and 
D711  or4  expressors  is  significantly  increased 
when compared to that of B8 control cells. In con- 
trast, the value obtained for the same cell line on 
H120- and Hg9-coated substrata are not statisti- 
cally significant. This was determined using a X~  2 
test, with a level of confidence >95%. 
The parental S180 cells migrate in a pattern similar to the 
host neural crest ceils, confirming some observations made 
previously (Erickson et al.,  1980).  The S180 cells only in- 
vade the anterior half of a somite (Fig. 8 A), and they never 
invade the posterior half (Fig. 8 B). Moreover, they invade 
the  somite along  the  interface between  the  myotome and 
sclerotome.  Neural  crest  cells  during  their  first  24  h  of 
migration do not enter the space between the ectoderm and 
dermatome (the dorsolateral space),and, likewise, the S180 
cells do not invade this path either (Table I; Fig. 8, A and B). 
S180 cell behavior differs from the host neural crest cells in 
two respects, however. S180 cells can migrate ventrally in the 
extracellular space between the somite and neural tube, as 
Figure 7. The Varani migration assay performed using L27 and P22 
cells. The cells were incubated at high density in culture medium 
containing 0.2 % low-melting agarose (final concentration) at 39°C 
for a few minutes, and small droplets of the cell suspension were 
deposited on FN-coated substrata and allowed to form an artificial 
cell aggregate as the droplets gelled. These droplets containing L27 
cells (grey rectangle) or P22 cells (white rectangle) were then in- 
cubated in culture medium for 24 or 40 h, fixed, and the area of 
L27 
GI 
(~  .~ 
24h  40h 
cell outgrowth was measured. In the case of L27 cells, ~e assay 
was also performed in the presence of mAbl6 antibody (black rec- 
tangle) or control Ig (hatched rectangle) at 0.1 mg/ml. Note that 
the L27 cells exhibit a greater ability than the P22 cells to escape 
from the aggregate, and their migration can be inhibited when the 
specific antibody mAb 16 is added to the culture medium. *All the 
values compared (speed of locomotion of L27 cells with or without 
Igs vs that of the P22 cells) were significantly different as deter- 
mined by a X~  2 test, with a level of confidence >95%. 
Beauvais et al. lntegrin Expression Pattern Regulates Cell Motility In Vivo  707 Figure 8.  Fluoro-gold-labeled  S180 cells or transfected cells lines grafted into the trunk neural crest migratory pathway. Embryos were 
fixed 18 h after receiving the graft and were subsequently sectioned. The S180 cells and transfected cells are labeled with Fluoro-gold 
and appear blue (A-G), whereas the neural crest cells are labeled with HNK-1 and a rhodamine-conjugated secondary antibod~ and appear 
red (A, E, F, and G). (A) Section taken through the anterior half of a somite reveals that the S180 cells and the neural crest cells follow 
similar migratory paths, although neural crest cells are generally dispersed farther. Note that neither neural crest cells nor S180 cells are 
in the dorsolateral path. Bar, 50 #m (also for B, D, E, F, and G). (B) Section through the posterior half of a somite showing that the 
S180 cells do not invade that portion of the somite and remain aggregated at the graft site. (C) Section through the anterior ~omite half 
reveals a5 expressors at the interface between the m~(otome and sclerotome, in the dorsolateral  path, and in the space between the sclerotome 
and neural tube. Note the very long cell processes that these cells extend (arrowheads). Bar,  100/~m.  (D) Higher magnification of c~5 
expressor cells migrating extensively in the dorsolateral path. This section passes through the posterior half of the somite, and no grafted 
cells are found in the sclerotome. (E) Section through an embryo into which c~4 high expressor cells were grafted. Although these cells 
display short cell processes (arrowheads), they do not disperse as single cells from the graft site. The small cluster of S180 cells near 
The Journal of Cell Biology,  Volume 128, 1995  708 Table L Quantification of Cells That Have Invaded the Neural Crest Dorsolateral Pathway after They Have Been Implanted 
in the Embryo for 18 h 
Cell type  S180  L27  D828 (low)  D711 (high) 
No.  of embryos  10  7  7  7 
No.  of cells/embryo in  1.80  +  0.69  9.85  +  1.26  7.85  +  1.14  1.14  +  0.55 
dorsolateral path (mean  +  SE) 
There is a highly significant increase (P =  0.0001)  in the number of L27 and D828 cells found in this particular  pathway when compared to control or D711 
cells using a Student's t test assuming unknown and unequal variances. 
far ventral as the notochord. Neural crest cells are generally 
not found in this space any farther ventral than the myotome 
at this stage of migration.  A  second difference is that the 
S180 cells do not disperse as far (and therefore as fast) as the 
host neural crest cells. 
The L27 cells migrate through the anterior sclerotome in 
a pattern similar to the S180 cells (Fig. 8, C and D). In addi- 
tion, they also migrate ventrally, often along the basal sur- 
face of the neural tube. Their patterns and mode of migration 
diverge from the parental  line in two important respects. 
First, the L27 cells were observed in relatively large num- 
bers in the dorsolateral path, where host crest cells will not 
appear for at least another 24 h (Table I; see Erickson et al., 
1992). Thus, the et5-transfected cells appear to be able to ex- 
ploit a pathway that is not accessible to early migratory neu- 
ral crest cells. Second, the L27 cells exhibit extremely long 
cell processes, whereas the S180 cells are relatively rounded 
and have very short processes. 
The c~4-transfected cell lines behave differently than either 
the S180 parental line or the ct5-transfected clones. Cells of 
the high expressor line scarcely move from their graft site, 
even though the cells clearly display very short processes 
(Fig.  8 E).  Occasionally, a  mass of the cells can be seen 
spreading along the basal surface of the myotome, but it in- 
vades only one or two cell lengths into the somite. Likewise, 
the graft as a whole occasionally spreads ventrally along the 
basement membrane of the neural tube. 
Cells of the low expressor or4 line disperse farther than 
their high expressor counterparts, although they do not mi- 
grate nearly as far as either the parental S180 cells or the a5- 
transfected cells. Two interesting features were noted about 
the pathways they exploit. Like the tx5-transfected cells, the 
low expressor tx4 cells are abundant in the dorsolateral path 
(Table I; Fig. 8 G). Second, these cells are nearly always ad- 
herent to basement membranes, either on the ectoderm or 
closely apposed to the myotome (Fig. 8, Fand G). They are 
rarely dispersed in the sclerotome, in contrast to the neural 
crest cells or the ct5-transfected cells. 
Discussion 
We have observed that modification of the expression pattern 
of FN-binding integrins at the surface of S180 cells produces 
changes  in  their  in vitro and in  vivo migratory behavior. 
These changes are dependent upon the types of integrins ex- 
pressed  as  well  as  their  prevalence.  Interestingly,  some 
aspects of the behavior observed in the embryo were not 
predicted based on the behavior of the same cells in tissue 
culture,  reinforcing the  importance of examining  cell be- 
havior in the tissue environment. 
Characterization  of  In Vitro Cell Behavior of 
u5-expressing Cells 
The parental S180 cells can theoretically interact with a FN- 
coated substratum using the ~3/~1,  c~v~l, av/~3, and c~5B1 
integrins,  all of which they express.  And,  in fact, the un- 
transfected  control  cells  readily  adhere  to  and  spread  on 
fibronectin. However, when the level of ~5/~1 is increased in 
L27 cells, they adhere and spread more rapidly than the par- 
ent cell line. In addition, they exhibit a more flattened mor- 
phology. This is consistent with previous studies that show 
that increased affinity to fibronectin, whether by increasing 
the concentration of integrins, the concentration of the ma- 
trix, or the strength with which integrins and matrix interact, 
results  in  an  increase  in  attachment,  spreading,  and  a 
modification in speed of movement and dispersion (Erickson 
and Turley, 1983; Rovasio et al., 1983; Tucker and Erickson, 
1984; Duband et al.,  1991;  Ffrench-Constant et al.,  1991). 
Since there is only a fivefold increase in the concentration 
of c~5/~t integrin on L27 cells, there is only a moderate in- 
crease in speed of movement. 
We can draw some interesting comparisons between our 
work and several other studies. Bauer and colleagues (1992) 
selected variants of CHO cells that expressed reduced levels 
of c~5/31 at their surface, a condition reversed from ours. The 
CHO variants exhibited slower migration than the parental 
line. Taken together with our data, there appears to be a di- 
rect correlation between the concentration of o~5~1 integrin 
and speed of movement, at least in this range of expression 
levels.  Giancotti and Ruoslahti (1990) have also generated 
CHO clones by transfection that express either 18 or 33 times 
more ot5B1 than is expressed by control CHO cells.  How- 
ever, they observed a decrease in cell motility using a wound 
healing repair assay. There are several possible explanations 
for this result, which at first glance seems contrary to ours. 
One possibility is based on the fact that our transfected cells 
only express five times the level of c~5 subunit, compared to 
the parental line, whereas the CHO cells expressed 18-33 
times more ~5 than the control cells. In the latter case, such 
a high level of or5 integrin may have immobilized the cells, 
as Duband et al.  (1991) demonstrated for neural crest cells 
when affinity is increased to very high levels. Thus, at some 
the notochord is revealed in adjacent sections to be contiguous with the rest of the graft.  (F and G) Sections through the anterior  half 
of a somite into which the low expressor ct4 cells (D828) have migrated. These cells are almost always found contacting basement mem- 
branes (arrowheads), either of the ectoderm or the myotome. These cells are relatively rounded with short cell processes, and they have 
not dispersed as extensively as the host neural crest cells. 
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affinity to the substratum that motility is reduced rather than 
increased. 
Alternatively, as a result of increased expression of the o~5 
subunit, both the CHO cells (Giancotti and Ruoslahti, 1990) 
and S180 cells (this report) demonstrate enhanced FN as- 
sembly at their surface. CHO cells may assemble so much 
matrix at their surface that they may become immobilized, 
perhaps because there are no longer any free receptors with 
which to generate motility. Thus, enhanced matrix assembly 
may be antagonistic to motility in some physiological condi- 
tions. 
In the Varani assay, the difference in rate of dispersion be- 
tween P22  and  L27 cells is  more pronounced than  their 
speed of movement measured in sparse and planar cultures. 
In the former assay, cells disperse from a droplet, where they 
are at high density, into a region of few cells. The assay does 
not measure  simply the intrinsic  migratory properties of 
cells, but a more complex behavior of cells in a mass. Thus, 
the greater difference observed between the migratory capa- 
bility of L27 vs P22 cells in this assay may reflect an en- 
hanced effect owing to population pressure and contact inhi- 
bition  of locomotion,  giving  rise  to  a  more  directional 
outward migration when compared to that of isolated cells. 
Indeed, contact inhibition of  migration has been proposed as 
the most plausible explanation for the directional movement 
of cells from a mass (Abercrombie, 1970; Heaysman, 1978; 
Erickson,  1988; Newgreen and Erickson,  1986). Recently, 
another  phenomenon  coined  "contact  stimulation  of mi- 
gration" has been described (Thomas and Yamada,  1992), 
where cells in high density pellets migrated outward with a 
greater velocity than when plated in sparse culture. Thomas 
and Yamada suggest that "contact inhibition of locomotion" 
and "contact-stimulated migration" can act synergistically in 
controlling cell velocity and directional movement. 
Characterization  of  In Vitro Cell Behavior of 
~4 Expressor Cells 
We examined the role of a4/~l expression in the attachment 
and spreading, as well as migration, of S180 cells on FN. 
a4fll clearly mediates attachment and spreading to FN-cell- 
binding domain II, depending on its expression level at the 
cell surface. The LDV sequence within this domain appears 
to be the major recognition site,  since the a4-expressing 
clones displayed identical levels of adhesion to the LDV- 
spliced variant (H95 and H0:2/~g/rnl) as the nonexpressing 
clones. The REDV site is probably involved, but to a lesser 
extent, since there is little difference in adhesion and spread- 
ing using the H120 variant (REDV+) and H89 (REDV-), 
and because the functional activity of this site is only re- 
vealed when H95 is used at high coating concentrations (10 
#g/ml). The IDAPS site in the heparin-binding domain does 
not facilitate binding since D828 and D711  cells adhere to 
the heparin-binding domain fragment (H0) minimally and to 
the same extent as cells of the B8 line, which do not express 
c~4/$1. The very slight adhesion observed on H0 fragments 
is likely caused by binding to the heparan-sulfate proteogly- 
can (HSPG)-binding site, and it suggests that S180 cells ex- 
press cell surface HSPG. 
The CS1 peptides do not dramatically reduce attachment 
and spreading on the spliced variants, whereas the L25 anti- 
body reduces attachment and spreading by >89 %. This is 
probably caused by relatively inefficient competition by CS1. 
Alternatively, it suggests the intriguing possibility that there 
is some synergism between the LDV site and sites in the 
heparin-binding domain,  since the antibody,  which is di- 
rected against the integrin, probably interferes with several 
integrin-binding sites to FN. Binding assays to a spliced vari- 
ant that does not contain the heparin-binding domain or the 
IDAPS site might address this possibility. 
The a4fll integrin also facilitates motility in addition to 
adhesion. The speed of movement is a function of the level 
of expression of ot4/31 at the surface, since the high expres- 
sors move more rapidly than the low expressors. Moreover, 
a4[31 may be more efficient than t~5fll in regulating motility 
since a fivefold increase in a5 produces only a  1.3-fold in- 
crease in L27 motility on fibronectin, whereas a fourfold in- 
crease in  ot4flt between the D711  cells  (high expressors) 
and D828 cells (low expressors) results in a 2.5-fold increase 
in motility (which can be abolished in the presence of L25 
antibody). 
In the Varani assay, the area of outgrowth is similar for the 
a4 expressors and control cells, which is surprising in light 
of the fact that in sparse culture, o~4 expressors are dramati- 
cally more motile than the controls. We have noted that the 
a4 expressor cells adhere to each other tenaciously, possibly 
owing to homotypic adhesive interactions (see discussion 
below). Speed of dispersion as measured in the Varani assay 
is dependent not only on cell-matrix affinity,  but also on 
cell-cell affinity. Thus, the balance between the two types of 
adhesion will determine rate of dispersion from a mass. In 
the two migration assays we used in this study, the results ob- 
tained in the Varani assay are consistent with the in vivo abil- 
ity of cells to migrate. However, it cannot replace the direct 
implantation of cells in the embryo, where the cells are ex- 
posed to a more complex environment than the planar sub- 
stratum with which the cells are confronted in the Varani 
assay. 
D828 cells and D711 cells migrate on FN cell-binding do- 
main II, and the speed of locomotion on these substrata is 
also dependent on the level of a4fll expression. LDV ap- 
pears to be the major site for generation of motility since 
there is a drastic reduction of speed of movement when this 
site is removed (compared motility on H89 and H0).  The 
REDV site apparently does not act synergistically with the 
LDV sequence to promote cell migration.  The slight de- 
crease in speed of movement of cells measured on H120 vs 
H89 substrata is not statistically significant, and the pres- 
ence of the REDV site on the substratum (H95 vs H0) does 
not induce an increase in cell motility. 
We observed that there is a low level of motility of D828 
and D711 cells on H0 fragments, which could be caused by 
either the IDAPS site recognized by o4/31 or the heparan sul- 
fate protemglycan-binding sites. It seems likely that motility 
on the H0 fragment results from c~4j31 interaction with the 
IDAPS site since B8 cells, which lack the o~4 subunit, can 
adhere poorly to, but do not migrate on,  H0-coated sub- 
strata. We have no evidence to support or exclude the idea 
that the HPSG-binding sites and the IDAPS site can act syn- 
ergistically to promote cell motility, nor can we rule out the 
possibility that other unidentified binding sites that regulate 
motility may yet exist in this domain. 
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the In Vivo Cell Behavior 
Three aspects of S180 cell behavior in vivo were altered by 
their acquisition of additional integrins: their morphology, 
their speed of movement, and the pathways they take in the 
embryo. Morphological changes appear to be similar in vitro 
and in vivo, whereas speed of motility was not predictable 
from our observations in culture. 
In culture, c~5 expressor cells on FN have a more flattened 
and elongated morphology when compared to that of  the par- 
ent cells or or4 expressors. It was interesting to observe that 
these cells had similar morphological characteristics in vivo. 
o~5 expressor cells exhibited long, thin processes that could 
extend many times the length of their cell bodies, whereas 
o~4 expressors remained rounded, although clearly extending 
short, stubby processes. These in vivo studies confirm the in 
vitro observation that o~5/31 is more functionally active in 
promoting cell spreading than ~4~1. 
The rate at which these grafted transfected cells migrate 
in vivo was not predictable, based on their behavior in cul- 
ture. In culture on FN, o~4/~1 integrin is a more potent in- 
ducer of cell motility, and speed of movement of the or4 ex- 
pressors increases dramatically with only a fourfold increase 
in the concentration of  the integrin. However, in vivo, the ~5 
expressors disperse more readily. There are several explana- 
tions for these differences. 
The rate of dispersion, within a certain range, is propor- 
tional to the avidity of attachment between cells and their 
substratum. And in fact, it has been demonstrated in vitro 
that the rate of migration is regulated by both the affinity of 
the integrin receptors for their ligands, by the number of 
receptors occupied, or the ligand density (Duband et al., 
1991; Lauffenburger, 1989).  Thus, the in vivo behavior of 
the cells is as likely to be controlled by the number of inte- 
grins as by the concentration and type of matrix with which 
they are confronted. Thus, one might imagine the possibility 
that the cell-binding domains recognized by cr5 or c~4 inte- 
grins are differentially exposed or available in the FN ma- 
trices in vivo than on FN-coated substrata in vitro. For exam- 
ple, the affinity to FN via c~5 may be relatively greater in the 
embryo than in our culture conditions due to the greater 
availability of the RGD-binding site. There is no evidence 
currently  concerning  the  relative  distribution  of various 
spliced variants of FN in the chicken embryo, although we 
are at least assured that the FN-spliced variant containing the 
LDV sequence is found in abundance in young (2.5-11-d old) 
chick embryos (Norton and Hynes, 1987).  A second possi- 
bility is that with a very large increase in affinity, cells are 
too strongly adherent to detach, and they therefore become 
immobilized (Duband  et al.,  1991; Erickson and Turley, 
1983;  Tucker  and  Erickson,  1994).  Thus,  the  high  ot4- 
transfected S180 cells may adhere so well in the embryonic 
environment that they are fixed in place, whereas in contrast, 
the low o~4 or the a5  expressors  are still able to migrate 
rapidly. 
Alternatively, the a4  expressor cells may disperse less 
well from the aggregates owing to homotypic adhesive inter- 
actions generated by the expression of the c~4 integrin. In 
fact, we consistently noted that pellets of D711  cells that 
were used in the grafting experiments always held together 
more tenaciously than pellets of the other cell lines, which 
fell apart readily. Moreover,  in sections through embryos 
into which D711 cells were grafted, the cells appear to ad- 
here to each other in aggregates in the position where they 
were grafted. This lack of  migration appears not to be caused 
by  poor  health  or  inability  to  migrate  since  small  cell 
processes were nevertheless produced. Such homotypic in- 
teractions could also explain the slow dispersal of the or4 ex- 
pressors in the Varani assay. A similar homotypic aggrega- 
tion has also been reported for other cells expressing u4#l 
integrins (Bednarczyk et al., 1993; Campanero et al., 1992; 
Pulido et al.,  1991; Qian  et al.,  1994;  Vonderheide and 
Springer, 1992), and at least in the case of melanoma cells, 
this homotypic aggregation is correlated with decreased mo- 
tility and invasiveness in vivo (Qian et al.,  1994).  While 
VCAM-1 and a4~81 have been documented to bind hetero- 
typically, S180 cells and the transfectants do not express 
VCAM-1 (data not shown). 
Perhaps the most provocative results of this study are that 
pathways of migration taken by different S180 cell lines are 
dependent on the integrins they express. Cells of the S180 
parent line, like the neural crest cells, do not invade the dor- 
solateral path, whereas the or5 expressor line and the low a,4 
expressor line invade this pathway immediately upon graft- 
ing and 24 h before the host neural crest cells. This is par- 
ticularly interesting in  light of the observation that only 
melanoblasts are able to invade the dorsolateral path and 
newly migrating neural crest cells acquire this invasive abil- 
ity only after 24 h either in vivo or in culture (Erickson and 
Goins, 1995). It is not known what cellular changes must oc- 
cur to confer this migratory ability on melanoblasts, but sev- 
eral  recent  reports  suggest that melanoblasts in  the  dor- 
solateral  path  or  NCC  express  either  the  ~4  (in  mice, 
Sheppard et al.,  1994;  in chicks, Stepp et al.,  1994) or o~5 
integrin (in chicks,  see Fig.  3  in Muschler and Horwitz, 
1991). Our work demonstrates that either c~5/~1 or ~4/$1 per- 
mits invasion, and taken together with the studies just cited, 
suggests that only after neural crest cells begin to express 
high levels of FN receptors will they exploit the dorsolateral 
path. Perhaps the receptors allow crest cells to adhere more 
tightly to the FN in this path (Newgreen and Thiery, 1980; 
Thiery et al., 1982) and to overcome what is initially a less 
satisfactory, or perhaps even inhibitory, migratory substra- 
tum (e.g., Erickson et al.,  1992;  Oakley et al.,  1994). 
Definitive studies using transgenic mice may shed more 
light on the role of integrins in neural crest migration and 
in melanoblast migration in particular.  In fact, mice with 
heterozygous null mutations in the genes encoding FN or the 
a5 integrin chain have been obtained (George et al.,  1993; 
Yang et al., 1993). The heterozygous mice lacking one allele 
of these genes appear to be normal, whereas those lacking 
two allelic genes coding for FN or or5 die by days 10-11 and 
present strong morphogenetic defects, indicating the essen- 
tial function of these molecules during early development 
(George et al., 1993; Yang et al., 1993).  Although the mal- 
formations obtained in the a5-null embryos suggest an im- 
portant role for this integrin during mesoderm formation and 
movement, it has not been reported if migratory properties 
of specific cell populations such as NCC were perturbed in 
these mouse embryos. 
These results do not indicate precisely which integrins can 
produce changes in neural crest behavior, or which account 
for their enhanced motility compared with other embryonic 
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least,  these results  indicate how various  integrins interact 
with the complex  extracellular matrix  environment of the 
embryo, and they can be used to verify or refute results ob- 
tained from culture experiments. Moreover, our in vivo be- 
havioral assay, as described in this report, can be used to test 
directly the migratory role of particular integrins that are ex- 
pressed by NCC and that are proposed from immunocyto- 
chemical studies to be correlated with neural crest behavior. 
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